Pharmaceutical firm Merck (MERK) booked net profit of Rp78 billion in 2019, dropped 93% from 2018. Its revenues rose 21.7% to Rp744.63 billion from previous Rp611.96 billion. Operating profit reached Rp125.59 billion, supported by gain of assets sale and other income. In 2018, MERK recorded profit after tax of Rp1.12 trillion from terminated operation.